Safety and Effects of Acetylated and Butyrylated High-amylose Maize Starch on Youths Recently Diagnosed with Type 1 Diabetes: A Pilot Study

Overview

Journal Diabetes Obes Metab

Specialty Endocrinology

Date 2024 Oct 28

PMID 39467812

Authors

Heba M Ismail

Jianyun Liu

Michael Netherland Jr

Nur A Hasan

Carmella Evans-Molina

Linda A DiMeglio

Affiliations

Soon will be listed here.

Citing Articles

From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes.

Blok L, Hanssen N, Nieuwdorp M, Rampanelli E Metabolites. 2025; 15(2).

PMID: 39997763 PMC: 11857261. DOI: 10.3390/metabo15020138.

Safety and effects of acetylated and butyrylated high-amylose maize starch on youths recently diagnosed with type 1 diabetes: A pilot study.

Ismail H, Liu J, Netherland Jr M, Hasan N, Evans-Molina C, DiMeglio L Diabetes Obes Metab. 2024; 27(2):987-992.

PMID: 39467812 PMC: 11700748. DOI: 10.1111/dom.16039.

References

Smart C, Annan F, Higgins L, Jelleryd E, Lopez M, Acerini C . ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2018; 19 Suppl 27:136-154. DOI: 10.1111/pedi.12738. View

Sorgdrager F, Naude P, Kema I, Nollen E, De Deyn P . Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target. Front Immunol. 2019; 10:2565. PMC: 6833926. DOI: 10.3389/fimmu.2019.02565. View

Blanton C, Moshfegh A, Baer D, Kretsch M . The USDA Automated Multiple-Pass Method accurately estimates group total energy and nutrient intake. J Nutr. 2006; 136(10):2594-9. DOI: 10.1093/jn/136.10.2594. View

Nel I, Beaudoin L, Gouda Z, Rousseau C, Soulard P, Rouland M . MAIT cell alterations in adults with recent-onset and long-term type 1 diabetes. Diabetologia. 2021; 64(10):2306-2321. PMC: 8336671. DOI: 10.1007/s00125-021-05527-y. View

Kim C, Park J, Kim M . Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw. 2015; 14(6):277-88. PMC: 4275385. DOI: 10.4110/in.2014.14.6.277. View

Darmaun D, Torres-Santiago L, Mauras N . Glutamine and type 1 diabetes mellitus: is there a role in glycemic control?. Curr Opin Clin Nutr Metab Care. 2018; 22(1):91-95. DOI: 10.1097/MCO.0000000000000530. View

Aryana K, Greenway F, Dhurandhar N, Tulley R, Finley J, Keenan M . A resistant-starch enriched yogurt: fermentability, sensory characteristics, and a pilot study in children. F1000Res. 2016; 4:139. PMC: 4712773. DOI: 10.12688/f1000research.6451.1. View

Yue T, Tan H, Wang C, Liu Z, Yang D, Ding Y . High-risk genotypes for type 1 diabetes are associated with the imbalance of gut microbiome and serum metabolites. Front Immunol. 2022; 13:1033393. PMC: 9794034. DOI: 10.3389/fimmu.2022.1033393. View

Ricci C, Rizzello F, Valerii M, Spisni E, Gionchetti P, Turroni S . Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial. Nutrients. 2022; 14(19). PMC: 9571173. DOI: 10.3390/nu14194208. View

10.

Hubbard T, Liu Q, Murray I, Dong F, Miller 3rd C, Smith P . Microbiota Metabolism Promotes Synthesis of the Human Ah Receptor Agonist 2,8-Dihydroxyquinoline. J Proteome Res. 2019; 18(4):1715-1724. PMC: 7886227. DOI: 10.1021/acs.jproteome.8b00946. View

11.

Pallister T, Jackson M, Martin T, Zierer J, Jennings A, Mohney R . Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome. Sci Rep. 2017; 7(1):13670. PMC: 5651863. DOI: 10.1038/s41598-017-13722-4. View

12.

Bell K, Saad S, Tillett B, McGuire H, Bordbar S, Yap Y . Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome. 2022; 10(1):9. PMC: 8772108. DOI: 10.1186/s40168-021-01193-9. View

13.

Ismail H, Liu J, Netherland Jr M, Hasan N, Evans-Molina C, DiMeglio L . Safety and effects of acetylated and butyrylated high-amylose maize starch on youths recently diagnosed with type 1 diabetes: A pilot study. Diabetes Obes Metab. 2024; 27(2):987-992. PMC: 11700748. DOI: 10.1111/dom.16039. View

14.

Zhang L, Wang Z, Zhang X, Zhao L, Chu J, Li H . Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy. Microbiol Spectr. 2022; 10(4):e0032422. PMC: 9430528. DOI: 10.1128/spectrum.00324-22. View

15.

Zhou H, Sun L, Zhang S, Zhao X, Gang X, Wang G . Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms. Front Endocrinol (Lausanne). 2020; 11:125. PMC: 7105744. DOI: 10.3389/fendo.2020.00125. View

16.

Ismail H, Perera D, Mandal R, DiMeglio L, Evans-Molina C, Hannon T . Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes. J Clin Endocrinol Metab. 2024; 110(2):364-373. PMC: 11747672. DOI: 10.1210/clinem/dgae529. View

17.

Ismail H, Spall M, Evans-Molina C, DiMeglio L . Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial. Pilot Feasibility Stud. 2023; 9(1):150. PMC: 10463339. DOI: 10.1186/s40814-023-01373-4. View